Education
About Us
Working with TipRanks
Follow Us
Cyfuse Biomedical K.K. (JP:4892)
:4892
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 231.00M | ¥ 54.45M | ¥ 61.11M | ¥ 374.48M | ¥ 708.25M |
| Gross Profit | ¥ 78.40M | ¥ 16.45M | ¥ 37.74M | ¥ 241.50M | ¥ 570.60M |
| Operating Income | ¥ -828.18M | ¥ -896.13M | ¥ -697.44M | ¥ -425.09M | ¥ 70.57M |
| EBITDA | ¥ -792.68M | ¥ -824.22M | ¥ -538.29M | ¥ -410.21M | ¥ 168.65M |
| Net Income | ¥ -763.84M | ¥ -872.24M | ¥ -589.21M | ¥ -473.96M | ¥ 142.91M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 3.73B | ¥ 3.05B | ¥ 3.87B | ¥ 4.44B | ¥ 2.41B |
| Total Assets | ¥ 4.27B | ¥ 3.52B | ¥ 4.21B | ¥ 4.82B | ¥ 2.65B |
| Total Debt | ¥ 1.31B | ¥ 852.00M | ¥ 913.00M | ¥ 908.14M | ¥ 569.06M |
| Net Debt | ¥ -2.41B | ¥ -2.20B | ¥ -2.96B | ¥ -3.53B | ¥ -1.84B |
| Total Liabilities | ¥ 1.51B | ¥ 975.60M | ¥ 1.01B | ¥ 1.05B | ¥ 746.12M |
| Stockholders' Equity | ¥ 2.76B | ¥ 2.54B | ¥ 3.20B | ¥ 3.77B | ¥ 1.90B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -581.93M | ¥ -769.10M | ¥ -581.77M | ¥ -631.87M | ¥ 161.54M |
| Operating Cash Flow | ¥ -534.79M | ¥ -760.55M | ¥ -562.30M | ¥ -403.60M | ¥ 161.54M |
| Investing Cash Flow | ¥ -397.56M | ¥ -8.64M | ¥ -19.47M | ¥ -430.67M | ¥ -50.58M |
| Financing Cash Flow | ¥ 1.26B | ¥ -52.01M | ¥ 18.24M | ¥ 2.66B | ¥ 229.21M |